| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $5K | -16.7% | -99.5% |
| Cost of Revenue | $55K | +34.1% | -96.0% |
| R&D Expense | $1.1M | +37.7% | -29.4% |
| SG&A Expense | $3.5M | -4.5% | -47.3% |
| Operating Income | -$4.8M | -2.7% | +58.2% |
| Interest Expense | $26K | +0.0% | +116.7% |
| Pre-tax Income | -$6.0M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $3K | +0.0% | -81.3% |
| Current Assets | $4.2M | -23.6% | +96.8% |
| Total Assets | $38.1M | -13.3% | +24.6% |
| Current Liabilities | $10.5M | -0.4% | -72.2% |
| Total Liabilities | $12.3M | -1.5% | -69.2% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.7M | — | — |
| Capital Expenditures | $17K | — | — |
| Investing Cash Flow | -$17K | — | — |
| Financing Cash Flow | $5.6M | — | — |
| Free Cash Flow | -$3.7M | — | — |
| +51.2% |
| -109.9% |
| Net Income | -$5.4M | +54.8% | -108.4% |
| EPS (Basic) | -$0.29 | +60.8% | -104.5% |
| EPS (Diluted) | -$0.29 | +60.8% | -120.1% |
| $32.5M |
| -13.3% |
| +767.9% |